Search results
There is a page named "Ralpancizumab" on Wikipedia
- Ralpancizumab (INN; development code RN317) is a monoclonal antibody designed for the treatment of dyslipidemia. This drug was developed by Pfizer. World...2 KB (115 words) - 23:17, 19 June 2023
Rafivirumab mab human rabies virus glycoprotein rabies (prophylaxis) Ralpancizumab mab humanized PCSK9 dyslipidemia Ramucirumab Cyramza mab human VEGFR2...135 KB (4,054 words) - 22:35, 2 July 2024- (4). Statement On A Nonproprietary Name Adopted By The USAN Council - Ralpancizumab, American Medical Association. "Sofituzumab Vedotin Overview - Creative...3 KB (164 words) - 14:55, 24 January 2024
